跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rotateq - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rotateq
Approved
STANDARD
Rotateq
Merck Sharp & Dohme Corp
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
047a3a19e0117987
Company
Merck Sharp & Dohme Corp
Type
Standard
Approval Details
Approval Id
047a3a19e0117987
Drug Approval Philippines Name
Rotateq
Product Name
Rotateq
Registration Number
BR-615
Brand Name
Rotateq
Generic Name
Rotavirus Vaccine, Live
Dosage Form
Solution For Oral Administration - Single Dose
Dosage Strength
2mL
Manufacturer
Merck Sharp & Dohme Corp
Trader
`
Importer
Merck Sharp & Dohme (I.A.) LLC
Company Detail Path
/organization/merck-sharp-and-dohme-corp
Issuance Date
08 September 2024
Expiry Date
02 August 2029
Pharmacologic Category
Vaccines
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
047a3a19e0117987
Type
Standard
Back to Philippines FDA Approvals